Barely Significant
← all phrases

“nominally significant”

7,733 sentences · 7,733 papers · 10,034 search hits before verification · confirmed specimen

Sighted at

p=0.08

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

nominally significantp = 0.0240.5× alphagold
During observation, nominally significant uncorrected effects were observed only in bilateral IFG (left IFG: hand − dot = − 0.142, 95% CI [− 0.263, − 0.021], p = 0.024, dz = − 0.49; right IFG: hand − dot = − 0.133, 95% CI [− 0.265, − 0.001], p = 0.049, dz = − 0.42), but these effects did not survive correction for multiple comparisons and were therefore treated as exploratory.
nominally significantp = 0.02480.5× alphagold
Efficacy end points in the ITT population Primary end point The difference in the average slope of change in 6MWD over 72 weeks between the ataluren and placebo groups was nominally significant (-0.74 m/week and -0.94 m/week in the ataluren and placebo groups, respectively; difference [95% CI]: 0.20 [0.03, 0.38]; p = 0.0248), equivalent to a 21% slower rate of decline in the ataluren group ( Table 3 ).
nominally significantp-value < 0.0250.5× alphagold
The null distribution was generated by recording the maximum CFE statistics at each of the 5000 permutations and a fixel is considered nominally significant if the whole-brain two-tailed family-wise error (FWE) corrected p-value < 0.025 (0.05/2).
nominally significantp = 0.0250.5× alphagold
The two co-primary endpoints were tested without multiple-comparison correction, given pre-specified hypotheses with separate rationales; the four-pattern and surgery-level AKI models were treated as exploratory, so the nominally significant GA–SA contrast ( p = 0.025) carries no confirmatory status.
nominally significantp = 0.0250.5× alphagold
Although no significant genetic loci were found in this analysis and only one of our Resilience genetic loci was nominally significant in the HRS GWAS (chromosome 3 locus; p = 0.025), there was a significant genetic correlation ( r g = −0.65, p = 1.5 × 10 −3 ) between cognitive change and Resilience .
nominally significantp = 0.0250.5× alphagold
Adjustment Disorders, Autism Spectrum Disorders, and Attention-Deficit/Hyperactivity Disorder For autism spectrum disorders, a nominally significant association was observed in Cohort 3 (HR 4.84, 95% CI 1.04–22.44; p = 0.025); however, this finding must be interpreted with extreme caution for multiple reasons: (1) very low absolute event counts (fewer than 10 per group); (2) wide confidence intervals reflecting statistical instability; (3) new ASD diagnoses in adults likely represent delayed recognition or diagnostic re-evaluation rather than true incident neurodevelopmental disease; and (4) the biological plausibility of a treatment effect on ASD within a 24-month window is limited.
nominally significantp = 0.0250.5× alphagold
Among iCMS2 tumours, aflibercept was associated with numerically improved outcomes without reaching statistical significance, whereas iCMS3 tumours exhibited a nominally significant PFS benefit (HR 0.66, p = 0.025), but this did not withstand FDR correction ( q = 0.100) and was not accompanied by an OS benefit.
nominally significantp = 0.0250.5× alphagold
A simultaneous cross-channel association analysis across all five channels finds that 19 of 20 pairwise Spearman correlations are non-significant; the single nominally significant result (pupil–duration, ρ = + 0.697 , p = 0.025 ) does not survive Bonferroni correction and is not robust to outlier removal.
nominally significantP = 0.0250.5× alphagold
For all-cause death, the intensive BP treatment × TyG interaction was nominally significant ( P = 0.025), whereas intensive BP treatment × CKM stage ( P = 0.230), intensive BP treatment × CKM stage × TyG ( P = 0.775), and the joint interaction test ( P = 0.116) were not significant.
nominally significantp = 0.0250.5× alphagold
Evaluating a total of 134 ATP1A2 polymorphisms genotyped using a combination of Illumina platforms (Cardiovascular Gene-centric 50 K SNP Array and HumanOmni1-Quad_v1-0_B Bead Chip), only one polymorphism ( rs2070704 ) demonstrated a nominally significant association with stroke in an age-, gender-, ethnicity-adjusted model (OR = 0.83, 95% CI = 0.71-0.98, p = 0.025) and in a vascular risk factor model adjusting for age, gender, ethnicity, hypertension, diabetes, smoking, and myocardial infarction (OR = 0.74, 95% CI = 0.63-0.89, p = 0.001).
nominally significantp = 0.0250.5× alphagold
Two of the four ( DNM2 ∼ LDL and TARS2 ∼ height) gene-trait pairs were replicated (beta = −0.203, SE = 0.089, p = 0.012 and beta = 0.053, SE = 0.018, p = 0.001 from the burden test, respectively) after multiple testing adjustment and another association ( ACAN -height) was nominally significant (beta = −0.094, SE = 0.045, p = 0.025 from the burden test).